Icosavax (ICVX) insider Simpson disposed of 1,141,765 shares

Insider transactions reported

Adam K. Simpson (insider at Icosavax Inc., ICVX) reported that they disposed of 1,141,765 shares on Feb 19, 2024. After these transactions the filing shows 0 shares held directly and 0 shares held indirectly (By family Trust).

Reporting person

Simpson Adam K.

Options and other derivatives

Holdings before and after

• Common Stock: 358,657 to 0 direct
• Common Stock: 525,044 to 0 indirect, By family Trust
• Stock Option (Right to Buy): 191,449 to 0 direct

Footnotes from the filing

1. 1. In connection with the terms of an Agreement and Plan of Merger, dated as of December 11, 2023 (the Merger Agreement ), by and among the Issuer, AstraZeneca Finance and Holdings Inc. ( Parent ), and Isochrone Merger Sub Inc., a wholly owned subsidiary of Parent ( Purchaser ), Purchaser completed a tender offer for shares of the Issuer's Common Stock at a purchase price per share of (i) $15.00 plus (ii) one non-tradable contingent value right ( CVR ) per share representing the right to receive a contingent payment of up to $5.00 in cash upon achievement of specified milestones (collectively, the Offer Price ). After completion of the tender offer, Purchaser merged with and into the Issuer (the Merger ), effective as of February 19, 2024 (the Effective Time ), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent.
2. 2. Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, this stock option was cancelled and converted into the right to receive, subject to the terms of the Merger Agreement, (a) an amount in cash equal to the product obtained by multiplying (1) the aggregate number of shares underlying such option immediately prior to the Effective Time by (2) an amount equal to (A) $15.00 less (B) the exercise price of such option, plus (b) one CVR for each share underlying such option immediately prior to the Effective Time.
3. 3. Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, this stock option was cancelled and converted into the right to receive, subject to the terms of the Merger Agreement, an amount in cash from Parent, if and when payments in respect of CVRs are required to be made, equal to the product obtained by multiplying (a) the aggregate number of shares underlying such option immediately prior to the Effective Time by (b) the amount by which (1) the sum of $15.00 plus the aggregate amount paid per CVR exceeds (2) the exercise price of such stock option.

FAQ